Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:1318-1324
Published online before print April 22, 2004, doi: 10.1161/01.RES.0000129182.46440.4a
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/10/1318    most recent
01.RES.0000129182.46440.4av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.
Right arrow Articles by Kruger, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.
Right arrow Articles by Kruger, W. D.
Related Collections
Right arrow Animal models of human disease
(Circulation Research. 2004;94:1318.)
© 2004 American Heart Association, Inc.


Molecular Medicine

Modulation of Cystathionine ß-Synthase Level Regulates Total Serum Homocysteine in Mice

Liqun Wang, Kwang-Hwan Jhee, Xiang Hua, Patricia M. DiBello, Donald W. Jacobsen, Warren D. Kruger

From the Division of Population Science (L.W., K.H.J., X.H., W.D.K.), Fox Chase Cancer Center, Philadelphia, Pa; and the Department of Cell Biology (P.M.D., D.W.J.), Lerner Research Center, Cleveland Clinic Foundation, Ohio. The present address for K.H.J. is the Department of Applied Chemistry, Kumoh National Institute of Technology, Korea.

Correspondence to Warren D. Kruger, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111. E-mail warren.kruger{at}fccc.edu

Elevated total plasma homocysteine is an independent risk factor in the development of vascular disease in humans. Cystathionine ß-synthase (CBS) is an enzyme that condenses homocysteine with serine to form cystathionine. In this article, we describe the effects of modulating CBS activity using a transgenic mouse that contains the human CBS cDNA under control of the zinc-inducible metallothionein promoter (Tg-CBS). In the presence of zinc, Tg-CBS mice have a 2- to 4-fold increase in liver and kidney CBS activity compared with nontransgenic littermates. Transgenic mice on standard mouse chow had a 45% decrease in their serum homocysteine (12.1 to 7.2 µmol/L; P<0.0001) when zinc was added to drinking water, although zinc had minimal effect on their nontransgenic siblings (13.2 µmol/L versus 13.0 µmol/L; P=NS). Tg-CBS mice maintained on a high-methionine, low-folate diet also had significantly lower serum homocysteine compared with control animals (179 µmol/L versus 242 µmol/L; P<0.02). CBS overexpression also significantly lowered serum cysteinylglycine (3.6 versus 2.8 µmol/L; P<0.003) levels and reduced the levels of many amino acids in the liver. We also found that expression of Tg-CBS rescued the severe hyperhomocysteinemia and neonatal lethality of Cbs deletion animals. Our results show that elevating CBS activity is an effective method to lower plasma homocysteine levels. In addition, the creation of an inducible mouse system to modulate plasma homocysteine will also be useful in the study of homocysteine-related vascular disease.


Key Words: metabolism • genetics • amino acids • cardiovascular diseases




This article has been cited by other articles:


Home page
CirculationHome page
D. Zhang, X. Jiang, P. Fang, Y. Yan, J. Song, S. Gupta, A. I. Schafer, W. Durante, W. D. Kruger, X. Yang, et al.
Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine {beta}-Synthase-Deficient Mice
Circulation, November 10, 2009; 120(19): 1893 - 1902.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Gupta, J. Kuhnisch, A. Mustafa, S. Lhotak, A. Schlachterman, M. J. Slifker, A. Klein-Szanto, K. A. High, R. C. Austin, and W. D. Kruger
Mouse models of cystathionine {beta}-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia
FASEB J, March 1, 2009; 23(3): 883 - 893.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Dayal and S. R. Lentz
Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1596 - 1605.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. T. Williams and K. L. Schalinske
New Insights into the Regulation of Methyl Group and Homocysteine Metabolism
J. Nutr., February 1, 2007; 137(2): 311 - 314.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. Li, L. Chen, R. W. Muh, and P.-L. Li
Hyperhomocysteinemia Associated With Decreased Renal Transsulfuration Activity in Dahl S Rats
Hypertension, June 1, 2006; 47(6): 1094 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Wang, X. Chen, B. Tang, X. Hua, A. Klein-Szanto, and W. D. Kruger
Expression of mutant human cystathionine {beta}-synthase rescues neonatal lethality but not homocystinuria in a mouse model
Hum. Mol. Genet., August 1, 2005; 14(15): 2201 - 2208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Shields, S. Lingrell, L. B. Agellon, J. T. Brosnan, and D. E. Vance
Localization-independent Regulation of Homocysteine Secretion by Phosphatidylethanolamine N-Methyltransferase
J. Biol. Chem., July 22, 2005; 280(29): 27339 - 27344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Chen, K.-H. Jhee, and W. D. Kruger
Production of the Neuromodulator H2S by Cystathionine {beta}-Synthase via the Condensation of Cysteine and Homocysteine
J. Biol. Chem., December 10, 2004; 279(50): 52082 - 52086.
[Abstract] [Full Text] [PDF]